Advertisement

Topics

Novartis' CANTOS Heart Trial Results Could Lead To Drastic Drop In Arthritis Drug Price

09:14 EDT 22 Jun 2017 | Forbes

But who would have thought at the results of a heart disease study could potentially provide an unexpected financial benefit to those patients with juvenile arthritis.

Original Article: Novartis' CANTOS Heart Trial Results Could Lead To Drastic Drop In Arthritis Drug Price

NEXT ARTICLE

More From BioPortfolio on "Novartis' CANTOS Heart Trial Results Could Lead To Drastic Drop In Arthritis Drug Price"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gout
According to the National Arthritis Data Workgroup, an estimated 6 million people in the United States report having experienced gout at some point in their lives. In fact, gout is the most common form of inflammatory arthritis in men over the age of 40....